West Pharmaceutical Services, Inc.WSTNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+8.5%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+8.5%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 16.13% |
| 2024 | -4.22% |
| 2023 | 11.52% |
| 2022 | -12.43% |
| 2021 | 19.83% |
| 2020 | 10.74% |
| 2019 | 3.73% |
| 2018 | 6.87% |
| 2017 | 2.59% |
| 2016 | 2.92% |